1551453-19-0

Basic information

• Product Name: 2,4-difluoro-N-(5-(4-(3-hydroxyprop-1-yn-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)benzenesulfonamide
• Synonyms: 2,4-difluoro-N-(5-(4-(3-hydroxyprop-1-yn-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)benzenesulfonamide
• CAS NO: 1551453-19-0
• Molecular Weight: 481.479
• Mol File: 1551453-19-0.mol

Chemical Properties

• CAS DataBase Reference: 2,4-difluoro-N-(5-(4-(3-hydroxyprop-1-yn-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-difluoro-N-(5-(4-(3-hydroxyprop-1-yn-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)benzenesulfonamide(1551453-19-0)
• EPA Substance Registry System: 2,4-difluoro-N-(5-(4-(3-hydroxyprop-1-yn-1-yl)quinolin-6-yl)-2-methoxypyridin-3-yl)benzenesulfonamide(1551453-19-0)

Safety Data

• Hazardous Substances Data: 1551453-19-0(Hazardous Substances Data)

Upstream product

• 1086063-46-8 N-(5-bromo-2-methoxypyridine-3-yl)-2,4-difluorobenzene sulfonyl chloride 
• 884495-39-0 5-bromo-2-(methyloxy)-3-pyridinamine 
• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 1086062-75-0 6-bromo-4-chloroquinoline hydrochloride 
• 927801-23-8 6-bromo-4-iodoquinoline 
• 65340-70-7 6-bromo-4-chloroquinoline 
• 152684-30-5 5-bromo-2-methoxy-3-nitropyridine 
• 145369-94-4 6-bromoquinolin-4-ol 
• 106-40-1 4-bromo-aniline 
• 187278-01-9 5-(((4-bromophenyl)amino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 1083326-73-1 N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)-2,4-difluorobenzenesulfonamide 
• 1551454-34-2 6-bromo-4-(3-hydroxyprop-1-yn-1-yl)quinoline 

Relevant articles and documents

PI3 kinase modulators and methods of use thereof, and use thereof

The invention belongs to the field of medicines, concretely relates to a compound for treating cancer, a composition and an application of the composition and particularly relates to a PI3 kinase regulator as well as a use method and application of the PI3 kinase regulator. The invention provides a compound as shown in the formula (I), a pharmaceutically accepted salt of the compound and a pharmaceutical preparation of the compound, wherein the compound is used for regulating the activity of protein kinase and intercellular or intracellular signal response. The invention also relates to a pharmaceutical composition containing the compound and a method for treating high-proliferative diseases of mammals and particularly human beings by using the pharmaceutical composition as shown in the formula (I).

PI3 KINASE MODULATORS AND METHODS OF USE

This invention relates to the field of lipid kinases and modulators thereof. In particular, the invention relates to modulators of phosphatidylinositol 3-kinases (PI3 kinases or PBKs) signaling pathways, and methods of their use. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in modulating of PI3K signaling pathways and their related disorders in mammals, especially humans.